AstraZeneca’s antibody cocktail failed to prevent COVID-19 symptoms in large trial
AstraZeneca said a late-stage trial failed to provide evidence that its COVID-19 antibody therapy protected people who had contact with an infected person from the disease.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
